Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger
Special Investor Call will be held Wednesday, July 7, at 8:30 a.m. ET
FORT COLLINS, Colo. and BUFFALO, N.Y., July 6, 2021 /PRNewswire/ — Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company developing novel approaches to activate…
